This paper is in the following e-collection/theme issue:

Non-Randomized Studies (funded, non-eHealth) (99)

Published on in Vol 7, No 12 (2018): December

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/11256, first published .
Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II Trial

Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II Trial

Benefits of Elective Para-Aortic Radiotherapy for pN1 Prostate Cancer Using Arc Therapy (Intensity-Modulated or Volumetric Modulated Arc Therapy): Protocol for a Nonrandomized Phase II Trial

Authors of this article:

Cédric Draulans 1 Author Orcid Image ;   Steven Joniau 2 Author Orcid Image ;   Valérie Fonteyne 3 Author Orcid Image ;   Louke Delrue 4 Author Orcid Image ;   Karel Decaestecker 5 Author Orcid Image ;   Wouter Everaerts 2 Author Orcid Image ;   Piet Dirix 6 Author Orcid Image ;   Laura Van den Bergh 7 Author Orcid Image ;   Wouter Crijns 1 Author Orcid Image ;   Hans Vandendriessche 8 Author Orcid Image ;   Lodewijk Van Wynsberge 9 Author Orcid Image ;   Piet Ost 3 Author Orcid Image ;   Nicolaas Lumen 5 Author Orcid Image ;   Pieterjan Buelens 1 Author Orcid Image ;   Karin Haustermans 1 Author Orcid Image ;   Charlien Berghen 1 Author Orcid Image ;   Gert De Meerleer 1 Author Orcid Image
Article Authors Cited by (7) Tweetations (4) Metrics
Cédric Draulans 1, MD;  Steven Joniau 2, MD, PhD;  Valérie Fonteyne 3, MD, PhD;  Louke Delrue 4, MD, PhD;  Karel Decaestecker 5, MD, PhD;  Wouter Everaerts 2, MD, PhD;  Piet Dirix 6, MD, PhD;  Laura Van den Bergh 7, MD, PhD;  Wouter Crijns 1, PhD;  Hans Vandendriessche 8, MD;  Lodewijk Van Wynsberge 9, MD;  Piet Ost 3, MD, PhD;  Nicolaas Lumen 5, MD, PhD;  Pieterjan Buelens 1, MD;  Karin Haustermans 1, MD, PhD;  Charlien Berghen 1, MD;  Gert De Meerleer 1, MD, PhD

1 Department of Radiation Oncology, University Hospitals Leuven, University of Leuven, Leuven , BE

2 Department of Urology, University Hospitals Leuven, University of Leuven, Leuven , BE

3 Department of Radiation Oncology, Ghent University Hospital, University of Ghent, Ghent , BE

4 Department of Radiology, Ghent University Hospital, University of Ghent, Ghent , BE

5 Department of Urology, Ghent University Hospital, University of Ghent, Ghent , BE

6 Department of Radiation Oncology , Iridium Cancer Network, Wilrijk, Antwerp , BE

7 Department of Radiation Oncology , Limburg Oncology Centre, Hasselt , BE

8 Department of Urology , AZ Jan Portaels, Vilvoorde , BE

9 Department of Urology , General Regional Hospital Tienen, Tienen , BE

Corresponding Author: